Innovent Biologics saw the highest growth of 124% in patent filings and 199% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 124% and grants by 199%. GlobalData’s DataBook provides a comprehensive analysis of Innovent Biologics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Innovent Biologics has been focused on protecting inventions in European Patent Office(EPO) with eight publications in Q4 2023

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 29% grants. The European Patent Office(EPO), United States(US), China(CN), and Australia(AU) patent Office are among the top ten patent offices where Innovent Biologics is filings its patents. Among the top granted patent authorities, Innovent Biologics has 29% of its grants in European Patent Office(EPO), 14% in United States(US) and 14% in Australia(AU).

Patents related to nanomedicine and rare diseases lead Innovent Biologics's portfolio

Innovent Biologics has the highest number of patents in nanomedicine followed by, rare diseases and immuno-oncology. For nanomedicine, nearly 33% of patents were filed and no patents were granted in Q4 2023.

Breast cancer related patents lead Innovent Biologics portfolio followed by lung cancer, and gastric cancer

Innovent Biologics has highest number of patents in breast cancer followed by lung cancer, gastric cancer, multiple myeloma (kahler disease), and post-transplant lymphoproliferative disorder.

For comprehensive analysis of Innovent Biologics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.